LEADERS FREE II Supports Biolimus Stent for High-Risk Patients LEADERS FREE II Supports Biolimus Stent for High-Risk Patients

LEADERS FREE II shows that results from the European LEADERS FREE trial apply to patients on ' both sides of the Atlantic ' who have a high bleeding risk and need a coronary stent.Medscape Medical News

Source: Medscape Medical News Headlines - September 23, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news